CAS Qingdao team develop single-cell precision diagnosis for Helicobacter pylori from gastric biopsy
CAS Qingdao team develop single-cell precision diagnosis for Helicobacter pylori from gastric biopsy
more insights
http://www.vlandbiochem.com/article-5545-10977.html
On March 14, 2024, Evonik Vland Biotech (Shandong) Co., Ltd. was put into operation in Qingdao, China. The joint venture of Evonik China Co., Ltd. and Shandong Vland Biotech Co., Ltd. aims to develop and expand gut health solutions products including probiotics for farm animals in China. Evonik holds the majority with a share of 55 %.
Head of Evonik’s life science division Nutrition & Care, the Animal Nutrition business line is Johann-Caspar Gammelin.
The joint venture is headquartered in Vland Biotech Innovation Park in Qingdao, China, and Vland’s production facilities in Binzhou, Shandong Province, China., will be utilized.
“Benefiting from the strong innovation capabilities, applied technology expertise and excellent reputation of the two parent companies, we will deliver innovative products and solutions to the market, and create more value for our customers,” says Dr. Wang Xu, general manager of Evonik Vland Biotech (Shandong) Co., Ltd.
Evonik and Vland Biotech form JV in Qingdao on animal gut health products
http://english.qibebt.cas.cn/ne/ns/202310/t20231027_397294.html
On Oct. 27, 2024, Prof. Juergen Popp Speaks, director of the Leibniz Institute of Photonic Technology and chair for Physical Chemistry at Friedrich-Schiller University, gave a talk at QIBEBT Distinguished Expert Forum and Visits Single-Cell Center on “Translational Biophotonics – Raman spectroscopy and AI a game changer !?” Popp elucidated the innovative technologies and potential applications of Raman spectroscopy in biophotonics, particularly its extensive use in clinical diagnostics. He emphasized the potential of multimodal methods combining Raman spectroscopy with other spectroscopic/optical technologies and how Raman can address today’s medical challenges, such as early cancer diagnosis and personalized treatments.
The visit was part of the Sino-German Scientific Partnership Program funded by the National Natural Science Foundation of China.
Professor Juergen Popp, University of Jena, gives talk at QIBEBT on “Translational Biophotonics”
https://doi.org/10.1016/j.checat.2024.101169
https://english.cas.cn/newsroom/research_news/chem/202411/t20241111_694029.shtml
Seawater electrolysis has long been seen as a promising pathway for sustainable hydrogen production but has faced significant limitations due to chloride ion (Cl⁻) corrosion, which can degrade a catalyst’s performance.
Scientists from the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of the Chinese Academy of Sciences, along with their collaborators, have developed an efficient electrocatalyst called Co-N/S-HCS that demonstrates remarkable activity and stability in seawater electrolysis. This offers a sustainable hydrogen production solution with minimal reliance on freshwater resources.
The Co-N/S-HCS electrocatalyst utilizes an asymmetric CoN₃S₁ structure, in which each cobalt (Co) atom is coordinated with three nitrogen (N) atoms and one sulfur (S) atom. This asymmetric CoN₃S₁ configuration, optimized through density functional theory and molecular dynamics simulations, modifies the electronic distribution around the Co center compared with the symmetric CoN4 configuration, thereby weakening corrosive Cl⁻ adsorption and enhancing the catalyst’s performance in seawater-based electrolytes.
QIBEBT: novel electro catalyst offers hydrogen production from seawater
Back to …
